Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy
- PMID: 15200275
- DOI: 10.1016/j.prp.2003.11.001
Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy
Abstract
Deficient activity of lysosomal acid lipase (LAL) results in massive accumulation of cholesteryl esters and triglycerides in most tissues of the body. The deficiency state is expressed in two major phenotypes: Wolman disease (WD) and cholesteryl ester storage disease (CESD). WD occurs in infancy and is nearly always fatal before the age of 1 year, whereas CESD can be more benign and may not be detected until adulthood. Since there are no specific routine laboratory observations that suggest these metabolic diseases, diagnosis is based on the clinical picture combined with LAL deficiency in cultured skin fibroblasts or peripheral lymphocytes. Both disorders are rather rare, considering that about a hundred of cases have been described up to now. This study describes the histological and ultrastructural aspects disclosed by intestinal or liver biopsy in three cases of WD and in two cases of CESD. Furthermore, it emphasizes the role of morphological findings in pointing the diagnosis towards a metabolic storage disease.
Similar articles
-
Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease.Gene. 2014 Apr 10;539(1):154-6. doi: 10.1016/j.gene.2014.02.003. Epub 2014 Feb 6. Gene. 2014. PMID: 24508470
-
Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage.Hum Mol Genet. 1998 Sep;7(9):1347-54. doi: 10.1093/hmg/7.9.1347. Hum Mol Genet. 1998. PMID: 9700186
-
Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease.Mol Genet Metab. 1998 Jun;64(2):126-34. doi: 10.1006/mgme.1998.2707. Mol Genet Metab. 1998. PMID: 9705237 Review.
-
[Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease].Nihon Rinsho. 1995 Dec;53(12):3004-8. Nihon Rinsho. 1995. PMID: 8577049 Review. Japanese.
-
Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.Genomics. 1996 Apr 1;33(1):85-93. doi: 10.1006/geno.1996.0162. Genomics. 1996. PMID: 8617513
Cited by
-
Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology.PLoS One. 2016 May 24;11(5):e0156113. doi: 10.1371/journal.pone.0156113. eCollection 2016. PLoS One. 2016. PMID: 27219619 Free PMC article.
-
Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation.Eur J Pediatr. 2014 Oct;173(10):1391-4. doi: 10.1007/s00431-014-2338-y. Epub 2014 May 21. Eur J Pediatr. 2014. PMID: 24844354
-
Macrophage-related diseases of the gut: a pathologist's perspective.Virchows Arch. 2012 Jun;460(6):555-67. doi: 10.1007/s00428-012-1244-9. Epub 2012 May 11. Virchows Arch. 2012. PMID: 22576700 Review.
-
Genetically modified mouse models to study hepatic neutral lipid mobilization.Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):879-894. doi: 10.1016/j.bbadis.2018.06.001. Epub 2018 Jun 5. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 29883718 Free PMC article. Review.
-
Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice.J Lipid Res. 2008 Aug;49(8):1646-57. doi: 10.1194/jlr.M700482-JLR200. Epub 2008 Apr 15. J Lipid Res. 2008. PMID: 18413899 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources